Bayer aims to crush consumer health rivals with $14B Merck unit buyout | PharmaBoardroom
written on 06.05.2014
Tags:
,

Bayer aims to crush consumer health rivals with $14B Merck unit buyout

TAGS: ,

And the winner is Bayer. After months of speculation–and reported bids from the likes of Sanofi, Novartis and Reckitt Benckiser–the German drugmaker has snagged Merck's consumer health unit in a $14.2 billion deal. The consumer buyout solidifies Bayer's position at the top of the global OTC game and provides Merck with a cardio collaboration–along with a hefty chunk of change.

Latest Report